South San Francisco, CA, United States of America

Mukund Mehrotra

USPTO Granted Patents = 20 


 

Average Co-Inventor Count = 7.2

ph-index = 7

Forward Citations = 208(Granted Patents)


Location History:

  • Winnipeg, CA (2014 - 2019)
  • South San Francisco, CA (US) (2008 - 2022)

Company Filing History:


Years Active: 2008-2022

Loading Chart...
Loading Chart...
Loading Chart...
20 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Mukund Mehrotra

Introduction:

Mukund Mehrotra, a renowned inventor based in South San Francisco, CA, has made significant contributions to the field of biopharmaceuticals. With a impressive portfolio of 20 patents, Mehrotra is known for his groundbreaking work in developing inhibitors of protein kinases for the treatment of various medical conditions.

Latest Patents:

Mukund Mehrotra's recent patents focus on inhibitors of protein kinases for the treatment of multiple myeloma and other related conditions. His inventions include compounds of Formula (I) and topical pharmaceutical compositions of Formula (If), which act as inhibitors of syk and/or JAK kinase activity. These innovative formulations have the potential to revolutionize the treatment of these diseases.

Career Highlights:

During his illustrious career, Mukund Mehrotra has worked with industry giants such as Portola Pharmaceuticals, Inc. and Gilead Sciences, Inc. His expertise and dedication have played a key role in advancing the development of novel pharmaceuticals and improving patient outcomes. Mehrotra's relentless pursuit of innovation has established him as a leading figure in the biopharmaceutical industry.

Collaborations:

Mukund Mehrotra has collaborated with talented individuals in his field, including coworkers Anjali Pandey and Shawn M Bauer. Together, they have worked on cutting-edge projects and research initiatives, pushing the boundaries of scientific exploration. Mehrotra's collaborative spirit and passion for innovation have led to successful partnerships and groundbreaking discoveries.

Conclusion:

In conclusion, Mukund Mehrotra's remarkable accomplishments in the field of biopharmaceuticals underscore his unwavering commitment to innovation and excellence. His pioneering work in developing inhibitors of protein kinases has the potential to transform the landscape of medical treatments. With a track record of success and a vision for the future, Mehrotra continues to inspire and shape the future of healthcare innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…